Skip to main content

Advertisement

Log in

Discovery of serum protein biomarkers in rheumatoid arthritis using MALDI-TOF-MS combined with magnetic beads

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

The aim of this study was to discover potential biomarkers for rheumatoid arthritis (RA) using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry combined with magnetic beads. Proteomic fingerprint technology combining magnetic beads with MALDI-TOF-MS was used to profile and compare the proteomes in serum samples from 60 patients with RA, 35 patients with osteoarthritis and 36 healthy controls. The proteomic pattern associated with RA was identified by Biomarker Patterns Software. Model of biomarkers was constructed and evaluated through the Biomarker Patterns Software. A total of 33 discriminative peaks were identified to be related with RA, in which the 5 peaks with the mass–charge ratio (m/z) peaks at 15,715.5, 7,771.4, 8,959.4, 8,469.8 and 8,710.8 Da were used to construct a model for the diagnosis of RA by pattern recognition software. The blind testing data indicated a sensitivity of 86.7% and a specificity of 90.0% in RA diagnosis. These results demonstrated that potential protein biomarkers for RA could be discovered in serum by MALDI-TOF-MS combined with WCX magnetic beads. The diagnosis mode tree based on the five candidate biomarkers could provide a powerful and reliable diagnostic method for RA with high sensitivity and specificity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Hoffman IE, Peene I, Pottel H et al (2005) Diagnostic performance and predictive value of rheumatoid factor, anti-citrullinated peptide antibodies, and the HLA shared epitope for diagnosis of rheumatoid arthritis. Clin Chem 51:261–263

    Article  PubMed  CAS  Google Scholar 

  2. Pincus T, Sokka T (2009) Laboratory tests to assess patients with rheumatoid arthritis: advantages and limitations. Rheum Dis Clin North Am 35:731–734

    Article  PubMed  Google Scholar 

  3. Steiner G, Smolen J (2002) Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res 4:S1–S5

    Article  PubMed  Google Scholar 

  4. Lee AN, Beck CE, Hall M (2008) Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review. Clin Lab Sci 21:15–18

    PubMed  CAS  Google Scholar 

  5. Maurya P, Meleady P, Dowling P et al (2007) Proteomic approaches for serum biomarker discovery in cancer. Anticancer Res 27:1247–1255

    PubMed  CAS  Google Scholar 

  6. Gámez-Pozo A, Sánchez-Navarro I, Nistal M et al (2009) MALDI profiling of human lung cancer subtypes. PLoS One 4:e7731

    Article  PubMed  Google Scholar 

  7. Shi L, Zhang J, Wu P et al (2009) Discovery and identification of potential biomarkers of pediatric acute lymphoblastic leukemia. Proteome Sci 7:7

    Article  PubMed  Google Scholar 

  8. Zhang X, Guo T, Wang H et al (2008) Potential biomarkers of acute cerebral infarction detected by SELDI-TOF-MS. Am J Clin Pathol 130:299–304

    Article  PubMed  CAS  Google Scholar 

  9. Zhou M, Veenstra T (2008) Mass spectrometry: m/z 1983–2008. Biotechniques 44:667–668, 670

    Google Scholar 

  10. Sparbier K, Wenzel T, Dihazi H et al (2009) Immuno-MALDI-TOF-MS: new perspectives for clinical applications of mass spectrometry. Proteomics 9:1442–1450

    Article  PubMed  CAS  Google Scholar 

  11. Wang P, Whiteaker JR, Paulovich AG (2009) The evolving role of mass spectrometry in cancer biomarker discovery. Cancer Biol Ther 8:1083–1094

    PubMed  CAS  Google Scholar 

  12. Pietrowska M, Marczak L, Polanska J et al (2009) Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer. J Transl Med 7:60

    Article  PubMed  Google Scholar 

  13. Guo R, Pan C, Shen J et al (2011) New serum biomarkers for detection of esophageal carcinoma using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Cancer Res Clin Oncol 137:513–519

    Article  PubMed  CAS  Google Scholar 

  14. Wang QT, Li YZ, Liang YF et al (2009) Construction of a multiple myeloma diagnostic model by magnetic bead-based MALDI-TOF mass spectrometry of serum and pattern recognition software. Anat Rec (Hoboken) 292:604–610

    Article  Google Scholar 

  15. Marshall J, Kupchak P, Zhu W et al (2003) Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J Proteome Res 2:361–372

    Article  PubMed  CAS  Google Scholar 

  16. Breiman L, Friedman JH, Olshen RA, Stone CJ (1984) Classification and regression trees. Wadsworth, Belmont

    Google Scholar 

  17. Van Vollenhoven RF (2009) Treatment of rheumatoid arthritis: state of the art 2009. Nat Rev Rheumatol 5:531–541

    Article  PubMed  Google Scholar 

  18. Wong SC, Chan CM, Ma BB et al (2009) Advanced proteomic technologies for cancer biomarker discovery. Expert Rev Proteomics 6:123–134

    Article  PubMed  CAS  Google Scholar 

  19. Choolani M, Narasimhan K, Kolla V et al (2009) Proteomic technologies for prenatal diagnostics: advances and challenges ahead. Expert Rev Proteomics 6:87–101

    Article  PubMed  CAS  Google Scholar 

  20. Wu T, Mohan C (2009) Proteomic toolbox for autoimmunity research. Autoimmun Rev 8:595–598

    Article  PubMed  CAS  Google Scholar 

  21. Kelleher MT, Fruhwirth G, Patel G et al (2009) The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients. Target Oncol 4:235–252

    Article  PubMed  Google Scholar 

  22. Peter JF, Otto AM (2010) Magnetic particles as powerful purification tool for high sensitive mass spectrometric screening procedures. Proteomics 10:628–633

    Article  PubMed  CAS  Google Scholar 

  23. Whiteaker JR, Zhao L, Zhang HY et al (2007) Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Anal Biochem 362:44–54

    Article  PubMed  CAS  Google Scholar 

  24. Li YZ, Hu CJ, Leng XM et al (2009) Promising diagnostic biomarkers for primary biliary cirrhosis identified with magnetic beads and MALDI-TOF-MS. Anat Rec (Hoboken) 292:455–460

    Article  CAS  Google Scholar 

  25. Visser H, le Cessie S, Vos K et al (2002) How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46:357–365

    Article  PubMed  Google Scholar 

  26. Goëb V, Thomas-L’Otellier M, Daveau R et al (2009) Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes. Arthritis Res Ther 11:R38

    Article  PubMed  Google Scholar 

  27. Huang Z, Shi Y, Cai B et al (2009) MALDI-TOF-MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of systemic lupus erythematosus. Rheumatology (Oxf) 48:626–631

    Article  CAS  Google Scholar 

  28. Komurasaki R, Imaoka S, Tada N et al (2010) LKM-1 sera from autoimmune hepatitis patients that recognize ERp57, carboxylester-ase 1 and CYP2D6. Drug Metab Pharmacokinet 25:84–92

    Article  PubMed  CAS  Google Scholar 

  29. Giusti L, Baldini C, Bazzichi L et al (2007) Proteomic diagnosis of Sjögren’s syndrome. Expert Rev Proteomics 4:757–767

    Article  PubMed  CAS  Google Scholar 

  30. Uchida T, Fukawa A, Uchida M et al (2002) Application of a novel protein biochip technology for detection and identification of rheumatoid arthritis biomarkers in synovial fluid. J Proteome Res 1:495–499

    Article  PubMed  CAS  Google Scholar 

  31. de Seny D, Fillet M, Meuwis MA et al (2005) Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteinchip approach. Arthritis Rheum 52:3801–3812

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Supported by grant 2007B225 from Medical Technology Program of Zhejiang and grant 2010C33001 from Science Technology of Zhejiang Province.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Bo Shen or Chibo Liu.

Additional information

Xiaoxue Zhang and Bo Shen equally contribute to the work as first coauthors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, X., Yuan, Z., Shen, B. et al. Discovery of serum protein biomarkers in rheumatoid arthritis using MALDI-TOF-MS combined with magnetic beads. Clin Exp Med 12, 145–151 (2012). https://doi.org/10.1007/s10238-011-0154-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-011-0154-5

Keywords

Navigation